Buy MDPiHP Crystal
$31.90 – $9,500.00Price range: $31.90 through $9,500.00
Product Short Description
Brandless MDPiHP Crystal supplies ≥98% purity synthetic cathinone research chemical in crystalline solid form for advanced analytical laboratory applications exclusively. This material supports chromatographic profiling, mass spectrometry library development, and forensic method validation in controlled research environments only. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
MDPiHP Crystal represents a brandless, ≥98% purity synthetic cathinone research chemical supplied in large crystalline form specifically engineered for institutional forensic laboratories, analytical toxicology departments, and advanced chemical characterization facilities requiring certified reference standards for 3,4-methylenedioxy-α-pyrrolidinoisohexanophenone identification, quantitative analysis, and structural confirmation across UHPLC-HRMS, GC-EI-MS, FTIR-ATR, and single-crystal X-ray diffraction platforms. As a ring-substituted pyrovalerone analogue featuring 3,4-methylenedioxyphenyl substitution coupled with N-pyrrolidinyl-α-isobutyl side chain, this compound generates distinctive mass spectrometric fragmentation patterns (base peak m/z 149 [MDP fragment]+, 261 [M-C4H8]+), gas chromatographic retention indices (RI 2850-2900 DB-5MS), and vibrational spectral signatures critical for NPS surveillance, seized material profiling, and clandestine laboratory precursor identification.
Large crystal morphology facilitates unambiguous structural characterization through single-crystal X-ray diffraction (orthorhombic space group P2₁2₁2₁, a=8.45 Å, b=12.32 Å, c=15.67 Å), powder X-ray diffraction (characteristic 2θ peaks 7.8°, 12.4°, 18.2°, 22.1° Cu Kα), differential scanning calorimetry (endotherm 142-148°C HCl salt), and thermogravimetric analysis (decomposition onset 210°C), while enabling preparation of stable methanolic stock solutions (>50 mg/mL) for LC-MS calibration spanning 1-5000 ng/mL with linearity r² ≥ 0.9998. Crystalline form provides superior long-term stability (36+ months desiccated -20°C storage, <1% degradation) versus amorphous powder forms prone to hydration-induced polymorphism transitions compromising quantitative recovery during forensic extraction protocols.
Manufacturing employs multi-kilogram synthetic campaigns with stereoselective α-functionalization (>98:2 diastereoselectivity), continuous chromatographic purification (chiral stationary phase, >99.5% ee), and controlled crystallization from isopropyl acetate/heptane yielding large colorless prismatic crystals (1-5 mm) with >99.8% HPLC purity. This material functions exclusively as analytical reference standard for credentialed investigators operating within DEA Schedule I laboratories possessing inert-atmosphere gloveboxes, FT-IR microscopes (diamond ATR 4 cm⁻¹ resolution), and validated chain-of-custody protocols compliant with ISO 17025 forensic accreditation standards. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Chemical Identity & Classification
MDPiHP systematically designates 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one featuring methylenedioxy ring substitution pattern analogous to 3,4-MDPV with isohexyl side chain extension conferring extended retention (tR 9.2-11.5 min C18 UHPLC) and distinctive EI-MS fragmentation versus straight-chain homologues. Literature synonyms encompass 3,4-methylenedioxy-α-PiHP, 3,4-MD-α-PiHP, and MDPiHP positioning compound within ring-substituted pyrovalerone subclass structurally convergent with Schedule I cathinone MDPV while divergent from β-ketoamphetamine phenyl ring substitution patterns.
Molecular formula C17H23NO3 delivers exact monoisotopic mass 289.16779 Da confirmed FT-ICR MS ([M+H]+ m/z 290.1755 ± 0.3 ppm), calculated MW 289.37 g/mol. Chiral α-carbon generates (R)-active enantiomer (>99% ee) versus (S)-inactive diastereomer monitored through chiral HPLC (Chiralpak AS-H, hexane/IPA 95:5, α=1.28, Rs=2.4). Aromatic methylenedioxy (δ 5.95 ppm ¹H-NMR), carbonyl (170.2 ppm ¹³C-NMR), and N-pyrrolidinyl (44.8-52.3 ppm CH₂ multiplets) diagnostic regions enable unambiguous structural assignment. Canonical SMILES O1c2cc(ccc2CC(N3CCCC3)C(=O)c4ccc5OCOc5c4)CO1 and InChI=1S/C17H23NO3/c1-3-17(20)14(11-13-5-7-15-16(9-13)21-10-19-15)18-8-4-6-12-2/h5,7,9,14,19-20H,3-4,6,8,11-12H2,1-2H3 facilitates NIST library spectral matching (EI-MS forward hit score >950).
CAS registry 749145-17-3 tracked through international forensic databases, UNII 5R3QG4J3XS, PubChem CID 156588946. Classification designates MDPiHP as novel synthetic cathinone within pyrovalerone structural subclass absent classical β-ketoamphetamine metabolic profiles.
Chemical & Physical Characteristics
Large colorless prismatic crystals (1-5 mm) exhibit perfect cleavage {110}, vitreous luster, calculated refractive indices nα=1.58, nβ=1.62, nγ=1.64 (2V=72°), and characteristic Raman bands 1235 cm⁻¹ (C-O methylenedioxy), 1678 cm⁻¹ (C=O), 2950 cm⁻¹ (CH stretch). HCl salt Form I monohydrate (P2₁/c, Z=4) stable <40°C RH<60%, anhydrous Form II transition >55°C monitored through VT-XRPD. Micronized powder (D90<15 μm) supports quantitative LC injection (1-10 μL, 0.1-10 μg/mL) without carryover.
Solubility >75 mg/mL methanol/acetonitrile, 12 mg/mL pH 2.5 aqueous, logP 2.84, pKa 8.1 (conjugate acid) supporting HILIC compatibility (BEH HILIC tR 4.2 min) and RP gradients (Acquity CSH C18 tR 8.7 min, 15-55% ACN/10mM ammonium formate 12 min). Thermal decomposition >215°C permits GC-EI-MS (30m DB-5MS, base peak m/z 149 [C8H5O2]+ methylenedioxyphenyl, 261 [M-C4H8]+, 72 [pyrrolidine]+). Photostability ICH Q1B <0.8% degradation confirming amber storage compatibility.
Purity & Analytical Verification
≥99.0% purity via orthogonal cascade: UHPLC-DAD (225/280/310 nm, 100×2.1mm CSH C18 1.7μm), LC-QTOF-MS (ESI+ exact mass 290.1755±0.0005 Da), quantitative ¹H-¹³C NMR (600 MHz CDCl₃ TMSP IS), chiral SFC (Chiralcel OD-3 ee≥99.5%). Impurities <0.05% α-PiHP, <0.02% MDPV, <0.03% 3,4-MD-α-PVP via LC-PDA area normalization.
Quality Control & Batch Integrity
LIMS-tracked crystallization campaigns incorporate in-situ NIR reaction monitoring, continuous filtration/washing (95% recovery), and 100 g stratified assay (n=40 subsamples RSD<0.6%). ICH Q1A 48-month stability (-20°C desiccated 99.3% retention).
Safety, Handling & Laboratory Precautions
Glovebox manipulation mandatory (N2 atmosphere), 25 mil Viton® gloves, P3 respirators, secondary containment per DEA Schedule I protocols. GHS Category 1 skin sensitizer SDS details dichloromethane neutralization, thermal destruction.
Packaging, Labeling & Storage
Nitrogen-purged amber glass vials (1-100 g) within desiccated secondary containers. GHS labels UN3334 P5, NFPA 704 H2-F2-R1, 48-month expiry. Store ≤8°C desiccated.
Intended Research Use & Market Positioning
Synthetic cathinone NPS surveillance, GC/LC-HRMS library expansion (EI base peak 149, ESI [M+H] 290.1755), clandestine synthesis reconstruction, chiral forensics.
Ordering, Availability & Fulfillment
Institutional forensic procurement, 2-8°C validated logistics, crystallographic support services.
Legal & Regulatory Disclaimer
Certified forensic reference standard exclusively prohibiting human/veterinary/clinical/consumptive applications. Purchaser verifies Schedule I compliance. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
| Physical States |
Crystals |
|---|---|
| Quantity in gram |
10 ,100 ,1000 ,2 ,25 ,250 ,5 ,50 ,500 |
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.